Skip to content
JANX Janux Therapeutics, Inc. Common Stock
$40.61 -0.10% -0.04
Notify me if price changes either direction
Interactive Brokers Logotype

Buy JANX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 2.4B
Enterprise value 1.5B
Trailing PE -30.84848577326
Forward PE -25.696877
PEG Ratio -25.696877
Enterprise to EBITDA -17.842
Enterprise to revenue 114.691
Price to book MRQ 3.2794929
Price to sales TTM 184.74118

Financials

Fiscal Year Ends 2023-12-31
Most Recent Quarter (MRQ) 2024-09-30
Revenue (TTM) 13M
EBITDA -83883000
Diluted EPS TTM -1.17
Total Cash (MRQ) 658M
Current ratio (MRQ) 38.801
Operating Cash Flow (TTM) -36990000

JANX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
75% sells
25% buys
Upgrade Today
In the last 0 months

Recent JANX News

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account?

Services

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.